Roche Holding AG RHHVF
As ofNov 16, 2026, 9:35 AM EST
- YTD
- +18.42%
- 1 year
- +35.81%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
P/E against peers
Price over the last twelve months of earnings, RHHVF and similar companies
RHHVF trades at 25.3 times earnings, 45% below its peers' median of 46.4.
Peers’ median 46.4. A bar with a notched end runs past the scale. Peers are companies in a similar business; a P/E alone does not say whether a stock is cheap.
Financial health
Altman Z-Score
4.68 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B+3 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 2
- P/B 1
Valuation
Profitability
Growth (YoY)
Financial Health
Dividends
Annual · latest fiscal year ends 2025-12-31
